Age and Sex Correlation with WHO Clinical Stages of HIV-1 Patients in Khartoum State, Sudan 2020

Nafisa A Dawood; Khalid A Enan; Mahdi M Yagoup; Waleed A Hussein; Wafa I Elhag

doi:10.32628/IJSRST23210145

Authors

Nafisa A Dawood Lecturer Department, Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan Author https://orcid.org/0000-0002-7146-799X
Khalid A Enan Associate Professor, Department of Virology, Central Laboratory, Sudan Author https://orcid.org/0000-0002-2548-879X
Mahdi M Yagoup Master of Public Health. E. mail: mahdiyagoub@hotmail.com. , Senior HIV Clinical Mentor/ Case Management Unit DCD. Federal Ministry of Health. Sudan Author https://orcid.org/0009-0005-3260-9130
Waleed A Hussein Associate Professor, Department of Microorganisms and Clinical Parasitology - College of Medicine- University of BISHA-61922, Saudi Arabia Author https://orcid.org/0000-0001-5074-1147
Wafa I Elhag Department of Microorganisms and Clinical Parasitology - College of Medicine- University of BISHA-61922, Saudi Arabia Author

DOI:

https://doi.org/10.32628/IJSRST23210145

Keywords:

Africa, HIV-1, Sudan, WHO Clinical Stages

Abstract

Background: The World Health Organization (WHO) clinical staging system for Human Immunodeficiency Virus (HIV) infection has been widely used in developing countries, especially in Africa, where there is no access to laboratory services and where it is not possible to assess the disease status using CD4+ T-lymphocyte counts.

Objective: This study aimed to detect the WHO clinical stages of HIV-1 patients in ART for 12±3 months attending different Voluntary counseling, testing, and treatment centers (VCT/ART) centers in Khartoum state, Sudan.

Methods: Data were obtained from 110 HIV-1 patients by a direct interviewing questionnaire, and information on WHO clinical staging was collected retrospectively on-site from patient records, then analyzed by Chi-squared test using SPSS version 21

Results: Most of WHO clinical stage 3 HIV-1 patients were males 56.7% (34/60), and the majority of them belonged to the age group 19-39 years 53.3% (32/60), followed by the age group 40-59 years old and 60-89 years old with percentage 36.7% (22/60) and 10% (6/60) respectively.

Conclusion: A significant relationship was obtained between age and WHO clinical stages, whereas there is no relationship with sex.

Downloads

Download data is not yet available.

References

WHO, W. H. O. (2015). HIV/AIDS - WHO Fact sheet. WHO website (Vol. 360).

Mohamed, B.A. and M.S. Mahfouz, Factors associated with HIV/AIDS in Sudan. BioMed research international, 2013. 2013. DOI: https://doi.org/10.1155/2013/971203

Sudan, U., HIV and AIDS Estimates. 2020.

UNAIDS. Sudan | UNAIDS. [cited 2020 15 March]; Available from: www.unaids.org › regionscountries › countries › sudan.

Edathodu, J., B. Ali, and A.A. Alrajhi, CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country. International Journal of Infectious Diseases, 2009. 13(2): p. 243-246. DOI: https://doi.org/10.1016/j.ijid.2007.12.017

Organization, W.H., Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance: African Region. 2005, World Health Organization.

Weinberg, J.L. and C.L. Kovarik, The WHO clinical staging system for HIV/AIDS. AMA Journal of Ethics, 2010. 12(3): p. 202-206. DOI: https://doi.org/10.1001/virtualmentor.2010.12.3.cprl1-1003

Teck, R., et al., WHO clinical staging of HIV infection and disease, tuberculosis, and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts. The international journal of tuberculosis and lung disease, 2005. 9(3): p. 258-262.

Kagaayi, J. et al., WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. Aids, 2007. 21(9): p. 1208-1210. DOI: https://doi.org/10.1097/QAD.0b013e32810c8dce

Fomundam, H., et al., Prevalence and predictors of late presentation for HIV care in South Africa. South African Medical Journal, 2017. 107(12): p. 1058-1064. DOI: https://doi.org/10.7196/SAMJ.2017.v107i12.12358

Fleishman, J.A., et al., The economic burden of late entry into medical care for patients with HIV infection. Medical care, 2010. 48(12): p. 1071. DOI: https://doi.org/10.1097/MLR.0b013e3181f81c4a

Ndiaye, B., et al., Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC infectious diseases, 2011. 11(1): p. 1-8. DOI: https://doi.org/10.1186/1471-2334-11-11

Dickson, N., et al., Late presentation of HIV infection among adults in New Zealand: 2005–2010. HIV medicine, 2012. 13(3): p. 182-189. DOI: https://doi.org/10.1111/j.1468-1293.2011.00959.x

Dokubo, E.K., et al., Awareness of HIV status, prevention knowledge and condom use among people living with HIV in Mozambique. Plos one, 2014. 9(9): p. e106760. DOI: https://doi.org/10.1371/journal.pone.0106760

Sogarwal, R. and D. Bachani, Awareness of women about STDs, HIV/AIDS and condom use in India: Lessons for preventive programmes. Health and Population Perspectives and Issues, 2010. 32(3): p. 148-158.

Braitstein, P., et al., Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. Journal of women's health, 2008. 17(1): p. 47-55. DOI: https://doi.org/10.1089/jwh.2007.0353

Cornell, M., et al., The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical Medicine & International Health, 2009. 14(7): p. 722-731. DOI: https://doi.org/10.1111/j.1365-3156.2009.02290.x